Related references
Note: Only part of the references are listed.The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study
Serena Di Cosimo et al.
EUROPEAN JOURNAL OF CANCER (2019)
Breast cancer statistics, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Effect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation
Sen Guo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
Licai He et al.
SCIENTIFIC REPORTS (2017)
Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host
Martina Di Modica et al.
DISEASE MARKERS (2017)
Tumor microenvironment-mediated chemoresistance in breast cancer
Kobra Velaei et al.
BREAST (2016)
Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2+breast cancer: preliminary results
Anna G. Sorace et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Predictive biomarkers in the treatment of HER2-positive breast cancer: an ongoing challenge
Tiziana Triulzi et al.
FUTURE ONCOLOGY (2016)
Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity
Sabina Sangaletti et al.
CELL REPORTS (2016)
Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment
Maria G. Garcia-Mendoza et al.
BREAST CANCER RESEARCH (2016)
Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial
G. Bianchini et al.
ANNALS OF ONCOLOGY (2015)
Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastuzumab Trials
Ciara C. O'Sullivan et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Improving drug delivery to solid tumors: Priming the tumor microenvironment
Iftikhar Ali Khawar et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Naoko Takebe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
The impact of tumor stroma on drug response in breast cancer
Juergen Dittmer et al.
SEMINARS IN CANCER BIOLOGY (2015)
Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression
Marta Giussani et al.
SEMINARS IN CANCER BIOLOGY (2015)
Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration
Tiziana Triulzi et al.
ONCOTARGET (2015)
Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex
Naoshad Mohammad et al.
SCIENTIFIC REPORTS (2015)
Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy
M. I. Koukourakis et al.
BRITISH JOURNAL OF CANCER (2014)
Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study
Aleix Prat et al.
CLINICAL CANCER RESEARCH (2014)
Maspin influences response to doxorubicin by changing the tumor microenvironment organization
Tiziana Triulzi et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Molecular Features and Survival Outcomes of the Intrinsic Subtypes Within HER2-Positive Breast Cancer
Aleix Prat et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Epithelial-Mesenchymal Transition and Drug Resistance: Role, Molecular Mechanisms, and Therapeutic Strategies
Hua Sui et al.
ONCOLOGY RESEARCH AND TREATMENT (2014)
Neoplastic and Stromal Cells Contribute to an Extracellular Matrix Gene Expression Profile Defining a Breast Cancer Subtype Likely to Progress
Tiziana Triulzi et al.
PLOS ONE (2013)
Correction: Association between SPARC mRNA Expression, Prognosis and Response to Neoadjuvant Chemotherapy in Early Breast Cancer: A Pooled in-silico Analysis
Hatem A. Azim et al.
PLoS One (2013)
TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab
Stefan Glueck et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Treatment of HER2-positive breast cancer: current status and future perspectives
Carlos L. Arteaga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
Mikala Egeblad et al.
DEVELOPMENTAL CELL (2010)
Identification of Subtypes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome
Johan Staaf et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
FINDING LARGE AVERAGE SUBMATRICES IN HIGH DIMENSIONAL DATA
Andrey A. Shabalin et al.
ANNALS OF APPLIED STATISTICS (2009)
Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells
S. C. Kirkland
BRITISH JOURNAL OF CANCER (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer
Chirayu Shah et al.
CLINICAL CANCER RESEARCH (2009)
Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab
Alessandra Magnifico et al.
CLINICAL CANCER RESEARCH (2009)
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
Pierre Farmer et al.
NATURE MEDICINE (2009)
T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
Achim Rody et al.
BREAST CANCER RESEARCH (2009)
Direct visualization of heterogeneous extravascular distribution of trastuzumab in human epidermal growth factor receptor type 2 overexpressing xenografts
Jennifer H. E. Baker et al.
CLINICAL CANCER RESEARCH (2008)
clValid: An R package for cluster validation
Guy Brock et al.
JOURNAL OF STATISTICAL SOFTWARE (2008)
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome
A. Bergamaschi et al.
JOURNAL OF PATHOLOGY (2008)
Radiation effects on development of HER2-positive breast carcinomas
Fabio Castiglioni et al.
CLINICAL CANCER RESEARCH (2007)
Drug penetration in solid tumours
Andrew I. Minchinton et al.
NATURE REVIEWS CANCER (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Neoadjuvant trastuzumab induces apoptosis in primary breast cancers
SK Mohsin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling
MPHM Jansen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
J-Express: exploring gene expression data using Java
B Dysvik et al.
BIOINFORMATICS (2001)
Share Paper
